AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES Stock

Certificat

DE000VD25XQ0

Real-time Boerse Frankfurt Warrants 07:56:42 2024-05-23 am EDT
100.8 EUR +0.21% Intraday chart for AKTIENANLEIHE - TEVA PHARMACEUTICAL INDUSTRIES
Current month+3.12%
1 month+4.97%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 100.8 +0.21%
24-05-22 100.6 -0.40%
24-05-21 101 -0.07%
24-05-20 101.1 +0.51%
24-05-17 100.6 -0.16%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 07:56 am EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Vontobel Vontobel
WKN VD25XQ
ISINDE000VD25XQ0
Date issued 2024-04-04
Strike 12 $
Maturity 2025-06-20 (394 Days)
Parity 0.01 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 101.5
Lowest since issue 94.99
Spread 11.3
Spread %1.11%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.88 USD
Average target price
17.54 USD
Spread / Average Target
+3.89%
Consensus